References
Essner R, Chung MH, Bleicher R, Hsueh E, Wanek L, Morton DL, Prognostic implications of thick (≥4-mm) melanoma in the era of intraoperative lymphatic mapping and sentinel lymphadenectomy.Ann Surg Oncol 2002;9:754–61.
Gershenwald JE, Mansfield PF, Lee JE, Ross MI. Role for lymphatic mapping and sentinel lymph node biopsy in patients with thick (>4.0mm) primary melanoma.Ann Surg Oncol 2000;7:160–5.
Cherpelis BS, Haddad F, Messina J, et al. Sentinel lymph node mlerometastases and other histology factors that predict outcome. In patients with thicker melanomas.J Am Acad Dermatol 2004;44:762–6.
Salti GI, Kansagra A, Warso MA, Ronan SG, Das Gupta TK, Clinical node-negative thick melanoma.Arch Surg 2002;137:291–5.
Reintgen DS, Rapaport DP, Tanabe KK, Ross MI. Lymphatic mapping and sentinel lymphadenectomy. In: Balch CM, Houghton AN, Sober AJ, Soong SJ, eds.Cutaneous Melanoma. St Louis: Quality Medical Publishing, 1989:725–44.
Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.J Clin Oncol 2001;19:3635–48.
Morton DL, Wen DR, Wong JH, et al. Technical details of intra-operative mapping for early stage melanoma.Arch Surg 1992;127:392–9.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thompson, J.F., Shaw, H.M. The prognosis of patients with thick primary melanomas: Is regional lymph node status relevant, and does removing positive regional nodes influence outcome?. Annals of Surgical Oncology 9, 719–722 (2002). https://doi.org/10.1007/BF02574492
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02574492